In conclusion, this study suggests that redo coronary surgery in general can be undertaken at low early mortality and at high 1-, 5-, and 10-year survival. It also shows that redo-OPCAB surgery is feasible and safe in this complex surgical scenario with better early in-hospital outcome compared to conventional redo-CABG and comparable high 10-year survival.